83 results
6-K
EX-99.1
ALVO
Alvotech
22 May 24
Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update
6:30am
by the movements in the exchange rate of foreign currencies, predominantly Icelandic krona and euros.
Income tax benefit: Income tax benefit was $6.4 million … venture
Finance income
Finance costs
Exchange rate differences
Non-operating loss
Loss before taxes
Income tax benefit
Loss for the period
Other
6-K
EX-99.2
ALVO
Alvotech
20 Mar 24
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
4:30pm
to joining Alvogen, Mr. Hardarson was Vice President of Tax and Structure at Actavis, and as partner, member of the executive management committee … , and served as a head of tax and legal at Deloitte. Mr. Hardarson holds a Master’s degree in law from the University of Iceland. We believe Mr. Hardarson
6-K
EX-99.1
ALVO
Alvotech
20 Mar 24
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
4:30pm
, predominantly Icelandic krona and euros.
Income tax benefits: The income tax benefit increased by $61.3 million for the year ended December 31, 2023 … , compared to the same period for 2022. This increase was mainly driven by $34.7 million deferred tax credit corresponding to an increase in operating losses
6-K/A
EX-99.1
zzyq qirp
30 Nov 23
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business Update
9:19am
6-K
EX-99.1
ntkqmu5ip
29 Nov 23
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business Update
7:00am
F-3
EX-4.5
zxl8bf3lq7v
20 Oct 23
Shelf registration (foreign)
4:06pm
F-3
ljzkcqii 2ys
20 Oct 23
Shelf registration (foreign)
4:06pm
F-3
EX-5.1
7uby9pc5
20 Oct 23
Shelf registration (foreign)
4:06pm
6-K/A
EX-99.1
87xeceg0nn95ksuc5t8
7 Sep 23
Current report (foreign) (amended)
1:06pm
6-K
EX-99.2
k58kxm n3bpyev
31 Aug 23
Current report (foreign)
8:00am
6-K
EX-99.3
vfmemj4
31 Aug 23
Current report (foreign)
8:00am
6-K
EX-99.5
1gcwl 6rhx
31 Aug 23
Current report (foreign)
8:00am
6-K
EX-99.1
n2zg9aqcaevkq
31 Aug 23
Current report (foreign)
8:00am
6-K
EX-99.6
m7f4jap0yse4
31 Aug 23
Current report (foreign)
8:00am
6-K
EX-5.1
ya7fnes
24 Jul 23
Provide Update on Strategic Biosimilars Partnership
4:15pm
424B3
5pqcp k84
24 Jul 23
Prospectus supplement
8:03am
424B3
if4r7n1
24 Jul 23
Prospectus supplement
8:00am
F-3
EX-5.1
2tz2buf6my8dfp
14 Jul 23
Shelf registration (foreign)
4:56pm